Reports Q4 revenue $199.2M, consensus $193.29M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITCI:
- Intra-Cellular downgraded to Hold from Buy at Canaccord
- Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond
- Reviva Pharmaceuticals price target lowered to $11 from $14 at H.C. Wainwright
- Intra-Cellular downgraded to Sector Perform from Outperform at RBC Capital
- Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations